Evidence for Taxotere treatment with solid tumors

T. Saeki, S. Takashima, Y. Sasaki, K. Ito, T. Igarashi, H. Minami, H. Fujii, K. Ishizawa, K. Kubota, S. Imoto

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Evidence based medicine is essential to further develop the state of the art for cancer treatments. We introduce the levels of evidence for Taxotere treatment against various solid tumors. Most evidence for Taxotere therapy was produced in other countries. However, in Japan we have some data from phase II clinical trials for the approval of Taxotere. We review these domestic results, which reveal its usefulness and toxicity in Japanese patients. In addition, we analyze the evidence from the data of clinical trials of Taxotere conducted by investigators in the USA/Europe. Japanese physicians or academies must build a consensus for the application of Taxotere to Japanese patients with solid tumors.

    Original languageEnglish
    Pages (from-to)1288-1293
    Number of pages6
    JournalGan to kagaku ryoho. Cancer & chemotherapy
    Volume27
    Issue number8
    Publication statusPublished - 2000 Jul

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Evidence for Taxotere treatment with solid tumors'. Together they form a unique fingerprint.

    Cite this